Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Acetaminophen recalled?

Yes — there is an active recall. 24 ongoing FDA recalls mention Acetaminophen (240 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Acetaminophen. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Acetaminophen recalls on record

none so far in 2026; 240 on record, newest first
Class II · Moderate risk

Acetaminophen Injection

Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Terminated Temperature excursion Baxter Healthcare Corporation NDC 36000-306-60 D-1348-2022
Class II · Moderate risk

Acetaminophen Oral Solution 650 mg / 20.3 mL

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 0904-6820-76 D-1486-2022
Class II · Moderate risk

Acetaminophen Oral Solution

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 0904-6739-71 D-1485-2022
Class II · Moderate risk

Acetaminophen Oral Solution 160 mg / 5 mL

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 0904-6738-70 D-1484-2022
Class II · Moderate risk

Back Relief II

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62959-740-00 D-0551-2022
Class II · Moderate risk

Normed Fem Tablet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62959-701-00 D-0549-2022
Class II · Moderate risk

APAP 325 mg

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62959-700-00 D-0548-2022
Class II · Moderate risk

Migrenol Caplet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62959-565-00 D-0547-2022
Class II · Moderate risk

HPC Tablet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62969-242-00 D-0538-2022
Class II · Moderate risk

Coated APAP 325mg

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62959-202-00 D-0532-2022